Update on HLA-B*15:02 allele associated with adverse drug reactions

被引:0
作者
Zhu, Xueting [1 ]
Luo, Guanghua [1 ]
Zheng, Lu [1 ]
机构
[1] Soochow Univ, Affiliated Hosp 3, Clin Med Res Ctr, Changzhou, Peoples R China
关键词
adverse drug reactions; antiepileptic drug; genetic marker; HLA-B*15:02; review; STEVENS-JOHNSON-SYNDROME; TOXIC EPIDERMAL NECROLYSIS; POLYMERASE-CHAIN-REACTION; HLA CLASS-I; INDUCED MACULOPAPULAR EXANTHEMA; GENETIC-MARKERS; RISK-FACTOR; B LOCUS; CARBAMAZEPINE; HAN;
D O I
10.2217/pgs-2023-0173
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
HLA alleles, part of the major histocompatibility complex, are strongly associated with adverse drug reactions (ADRs). This review focuses on HLA-B*15:02 and explores its association with ADRs in various ethnic populations and with different drugs, aiming to provide insights into the safe clinical use of drugs and minimize the occurrence of ADRs. Furthermore, the review explores the potential mechanisms by which HLA-B*15:02 may be associated with ADRs, aiming to gain new insights into drug modification and identification of haptens. In addition, it analyzes the frequency of the HLA-B*15:02, genotyping methods, cost-effectiveness and treatment measures for adverse reactions, thereby providing a theoretical basis for formulating clinical treatment plans.
引用
收藏
页码:97 / 111
页数:15
相关论文
共 50 条
  • [21] HLA-B*51: 01 is strongly associated with clindamycin-related cutaneous adverse drug reactions
    Yang, Y.
    Chen, S.
    Yang, F.
    Zhang, L.
    Alterovitz, G.
    Zhu, H.
    Xuan, J.
    Yang, X.
    Luo, H.
    Mu, J.
    He, L.
    Luo, X.
    Xing, Q.
    PHARMACOGENOMICS JOURNAL, 2017, 17 (06) : 501 - 505
  • [22] HLA-B*1502 is associated with aromatic anticonvulsant drug-induced cutaneous adverse drug reactions among the Hakka population in China
    Zheng, Zhiyuan
    Zhong, Hua
    Zhang, Qunji
    Huang, Qingyan
    Wu, Heming
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (03)
  • [23] Carbamazepine-Mediated Adverse Drug Reactions: CBZ-10,11-epoxide but Not Carbamazepine Induces the Alteration of Peptides Presented by HLA-B*15:02
    Simper, Gwendolin S.
    Ho, Gia-Gia T.
    Celik, Alexander A.
    Huyton, Trevor
    Kuhn, Joachim
    Kunze-Schumacher, Heike
    Blasczyk, Rainer
    Bade-Doeding, Christina
    JOURNAL OF IMMUNOLOGY RESEARCH, 2018, 2018
  • [24] HLA-associated antiepileptic drug-induced cutaneous adverse reactions
    Mullan, Kerry A.
    Anderson, Alison
    Illing, Patricia T.
    Kwan, Patrick
    Purcell, Anthony W.
    Mifsud, Nicole A.
    HLA, 2019, 93 (06) : 417 - 435
  • [25] HLA-A*02:07 Allele Associates with Clarithromycin-Induced Cutaneous Adverse Drug Reactions in Chinese Patients
    Chen, Sheng-An
    Zhang, Li-Rong
    Yang, Fan-Ping
    Yang, Lin-Lin
    Yang, Ying
    Chen, Zi-Hua
    Jiang, Meng-Lin
    Xiong, Hao
    Zhu, Hui-Zhong
    Qi, Zheng
    Xing, Qing-He
    Luo, Xiao-Qun
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 (03) : 308 - 313
  • [26] HLA-B*58:01 allele is associated with augmented risk for both mild and severe cutaneous adverse reactions induced by allopurinol in Han Chinese
    Cao, Zhi Hao
    Wei, Zhi-yun
    Zhu, Qin-yuan
    Zhang, Jun-yu
    Yang, Lun
    Qin, Sheng-ying
    Shao, Li-yan
    Zhang, Yi-ting
    Xuan, Jie-kun
    Li, Qiao-li
    Xu, Jin-hua
    Xu, Feng
    Ma, Li
    Huang, Hui-yuan
    Xing, Qing-he
    Luo, Xiao-qun
    PHARMACOGENOMICS, 2012, 13 (10) : 1193 - 1201
  • [27] Association of HLA-A and HLA-B Alleles with Lamotrigine-Induced Cutaneous Adverse Drug Reactions in the Thai Population
    Koomdee, Napatrupron
    Pratoomwun, Jirawat
    Jantararoungtong, Thawinee
    Theeramoke, Voralaksana
    Tassaneeyakul, Wichittra
    Klaewsongkram, Jettanong
    Rerkpattanapipat, Ticha
    Santon, Siwalee
    Puangpetch, Apichaya
    Intusoma, Utcharee
    Tempark, Therdpong
    Deesudchit, Tayard
    Satapornpong, Patompong
    Visudtibhan, Anannit
    Sukasem, Chonlaphat
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [28] Temporal trends and patterns in carbamazepine use, related severe cutaneous adverse reactions, and HLA-B*15:02 screening: A nationwide study
    Lin, Chih-Wan
    Huang, Wei-I
    Chao, Pi-Hui
    Chen, Wen-Wen
    Hsiao, Fei-Yuan
    EPILEPSIA, 2018, 59 (12) : 2325 - 2339
  • [29] HLA-A*24:02 as a common risk factor for antiepileptic drug-induced cutaneous adverse reactions
    Shi, Yi-Wu
    Min, Fu-Li
    Zhou, Dong
    Qin, Bin
    Wang, Juan
    Hu, Fa-Yun
    Cheung, Ying-Kit
    Zhou, Jin-Hua
    Hu, Xiang-Shu
    Zhou, Jue-Qian
    Zhou, Lie-Min
    Zheng, Zhong-zheng
    Pan, Jie
    He, Na
    Liu, Zhi-Sheng
    Hou, Yun-Qi
    Lim, Kheng-Seang
    Ou, Yang-mei
    Khor, Amy Hui-Ping
    Ng, Ching-Ching
    Mao, Bi-Jun
    Liu, Xiao-Rong
    Li, Bing-Mei
    Kuan, Yao-Yun
    Yi, Yong-Hong
    He, Xue-lian
    Deng, Xiao-Yan
    Su, Tao
    Kwan, Patrick
    Liao, Wei-Ping
    NEUROLOGY, 2017, 88 (23) : 2183 - 2191
  • [30] HLA-B Alleles and Lamotrigine-Induced Cutaneous Adverse Drug Reactions in the Han Chinese Population
    Shi, Yi-Wu
    Min, Fu-Li
    Liu, Xiao-Rong
    Zan, Li-Xuan
    Gao, Mei-Mei
    Yu, Mei-Juan
    Liao, Wei-Ping
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 (01) : 42 - 46